Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urban Novak

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Swiss Medical Weekly|July 26, 2018
Diagnosis and treatment of follicular lymphoma: an updateMario Bargetzi, Reto Baumann, Sergio Cogliatti, et al.
Blood|March 5, 2009
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomasUrban Novak, Andrea Rinaldi, Ivo Kwee, et al.
Hematological Oncology|August 17, 2018
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individualsAnnarita Conconi, Emanuele Zucca, Gloria Margiotta-Casaluci, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Blood|August 15, 2002
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, et al.
Blood Advances|August 30, 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party studySimon Renders, Maud Ngoya, Herve Finel, et al.
BMC Cancer|April 15, 2017
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)Bernhard C Pestalozzi, Christoph Tausch, Konstantin J Dedes, et al.
Acta Haematologica|December 2, 2025
Hemophagocytic Syndromes in Adults: Real-World Data on Mortality from a Tertiary Reference CenterTatiana Wojtovicova, Drahomir Aujesky, Joerg C Schefold, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2026
Prognostic role of FDG-PET in patients with relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies: a multicentric analysisSophie Wollnitza, David Ventura, Marcel Teichert, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Swiss Medical Weekly|July 26, 2018
Diagnosis and treatment of follicular lymphoma: an updateMario Bargetzi, Reto Baumann, Sergio Cogliatti, et al.
Blood|March 5, 2009
The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomasUrban Novak, Andrea Rinaldi, Ivo Kwee, et al.
Hematological Oncology|August 17, 2018
Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individualsAnnarita Conconi, Emanuele Zucca, Gloria Margiotta-Casaluci, et al.
Hemasphere|March 21, 2024
Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort studyPhilipp Berning, Evgenii Shumilov, Markus Maulhardt, et al.
Blood Advances|June 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin LymphomaSimon Leiders, Dominic Ufton, Helen Kaul, et al.
Blood|August 15, 2002
A high-resolution allelotype of B-cell chronic lymphocytic leukemia (B-CLL)Urban Novak, Elisabeth Oppliger Leibundgut, Jörg Hager, et al.
Blood Advances|August 30, 2024
Autologous stem cell transplantation in T-cell/histiocyte-rich large B-cell lymphoma: EBMT Lymphoma Working Party studySimon Renders, Maud Ngoya, Herve Finel, et al.
BMC Cancer|April 15, 2017
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10)Bernhard C Pestalozzi, Christoph Tausch, Konstantin J Dedes, et al.
Acta Haematologica|December 2, 2025
Hemophagocytic Syndromes in Adults: Real-World Data on Mortality from a Tertiary Reference CenterTatiana Wojtovicova, Drahomir Aujesky, Joerg C Schefold, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 1, 2026
Prognostic role of FDG-PET in patients with relapsed/refractory large B-cell lymphoma treated with CD3-CD20 directed bispecific antibodies: a multicentric analysisSophie Wollnitza, David Ventura, Marcel Teichert, et al.
Pageof 11